Protalix BioTherapeutics
PLX
#8349
Rank
S$0.29 B
Marketcap
S$3.62
Share price
6.11%
Change (1 day)
4.62%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): S$0.02295

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is S$0.02525. In 2024 the company made an earnings per share (EPS) of S$0.05050 a decrease over its 2023 EPS that were of S$0.15.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.02295-54.56%
2024S$0.05050-66.67%
2023S$0.15-138.71%
2022S-$0.39-50%
2021S-$0.78181.82%
2020S-$0.28-82.11%
2019S-$1.55-31.67%
2018S-$2.27-72.31%
2017S-$8.21124.14%
2016S-$3.66-147.54%
2015S$7.70-290.63%
2014S-$4.046.67%
2013S-$3.79130.77%
2012S-$1.64-69.77%
2011S-$5.4319.44%
2010S-$4.55-12.2%
2009S-$5.1836.67%
2008S-$3.79-37.5%
2007S-$6.0650%
2006S-$4.043.23%
2005S-$3.91138.46%
2004S-$1.64-74%
2003S-$6.31-0%
2002S-$6.31-50%
2001S-$12.63233.33%
2000S-$3.79-84.21%
1999S-$23.99-24%
1998S-$31.56-600%
1997S$6.31-16.67%
1996S$7.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.72 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$5.44 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.57 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel